References
- Barnes T. R., Ross M., Trauer T. A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals. Journal of Neurology Neurosurgery and Psychiatry 1983; 46: 540–546
- Bertolini A., Vergoni A. V., Poggioli G., Gessa G. L. Morphine and beta-endorphin antagonize posture and locomotor disorders induced by the injection of ACTH 1–24 in the rat locus coeruleus. Life Sciences 1986; 38: 373–377
- Casey D. E., Denney D. Pharmacological characterization of tardive dyskinesia. Psychopharma-cology 1977; 54: 1–9
- Gureje O. Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: Relationship to demographic, clinical, treatment, and neuropsychological variables. Journal of Neurology Neurosurgery ami Psychiatry 1988; 51: 1525–1530
- Jacquet Y. F. ‘Dystonia’-like postural asymmetry after microinjection of ACTH N-terminal fragments but not after ACTH 1–39 in rat brainstem suggests role of neuropeptide mutation in genetic movement disorder. Brain Research 1984; 294: 144–147
- Jacquet Y. F., Abrams G. M. Postural asymmetry and movement disorder after unilateral microinjection of adrenocorticotropic 1–24) in rat brainstem. Science 1982; 218: 175–177
- Kidger T., Barnes T. R.E., Trauer T., Taylor P. J. Sub-syndromes of tardive dyskinesia. Psychological Medicine 1980; 10: 513–520
- National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). Department of Health, Education and Welfare, Washington, D.C. 1974
- Rainero I., Kaye J. A., May C, Durson R., Katz D. I., Albert M. L., Wolfe N., Pinessi L., Friedland R. P., Rappoport S. I. Alpha-melanocyte-stimulating hormonelike immunoreativity is increased in cerebrospinal fluid of patients with Parkinson's disease. Archives of Neurology 1988; 45: 1224–1227
- Sandyk R. Alpha melanocyte stimulating hormone(MSH) in Tourette's syndrome. International Journal of Neuroscience 1989; 44: 161–164
- Sandyk R. Melanocyte-stimulating hormone in tardive dyskinesia. Biological Psychiarty, in press a
- Sandyk R. Melanocyte stimulating hormone and persistent tardive dyskinesia. International Journal of Neuroscience, in press b
- Shuster S., Thody A. L., Goolamali S. K., Burton J. L., Plummer N., Bates D. Melanocyte-stimulating hormone and parkinsonism. Lancet 1973; 1: 463–465
- Tarsy D., Granacher R., Bralower M. Tardive dyskinesia in voung adults. Archives of General Psychiatry 1977; 134: 1032–1034
- Thody A. J. The significance of melanocyte-stimulating hormone(MSH) and the control of its secretion in the mammal. Advances in Drug Research, N. J. Harper, A. B. Simmonds. Academic Press, London 1977; 23–74
- Veith J. L., Sandman C. A., George J. M., Stevens V. C. Effects of MSH/ACTH 4–10 on memory, attention and endogenous hormone levels in women. Physiology & Behavior 1978; 20: 43–50